Zogenix announced the submission of a New Drug Application (NDA) to the Food and Drug Administration (FDA) for Fintepla (low-dose fenfluramine; ... read more
NDA for Low-Dose Fenfluramine Submitted for Treatment of Dravet Syndrome
NDA for Low-Dose Fenfluramine Submitted for Treatment of Dravet Syndrome